2025-06-09-花旗集团-欧米茄医疗保健投资公司（OHI）_欧米茄医疗保健投资者（OHI.N）模型更新_11页_256kb

报告摘要

Flash Report: Omega Healthcare Investors (OHI.N) - Citi Research

Valuation Update

Citi raises its price target to US$45.00, implying a ~16x 2025E AFFO multiple. This is at a slight discount to healthcare peers but above its NAV estimate. The expected share price return is 22.0%, with an expected dividend yield of 7.3% and total expected return of 29.2%.

Financial Performance Update

Upgraded 2025 normalized FFO (Funds from Operations) estimate to $2.99 per share, up from $2.94. Key growth metrics include:

FFO Payout Ratio: 89.8% (2025E)
AFFO (Adjusted Funds from Operations): Expected payout ratio is 94.2% (2025E)

External Growth

Acquisition activity is a key driver: US$428M in 2024, US$1.055B in 2025 (pro-rata share).
Disposition activity decreased to US$95M in 2025.

Analyst Take & Thesis

Healthcare sentiment improving, potentially leading to multiple expansion above historical levels.
Key assumptions include improving fundamentals in healthcare and accretive acquisitions.

Risk Assessment

Upside Risk: Stronger reimbursements, favorable regulatory changes, higher than expected acquisitions.
Downside Risk: Insufficient government reimbursement, lower occupancy, compressed cap rates, or regulatory headwinds.